Vaccine against tuberculosis is being used in Russia and many other countries as the prevention of disease. American specialists plan to introduce BCG for the treatment of diabetes mellitus of the first type. Now the study turned into a second phase, soon the scientists scientific clinical trials of the drug. As the test group already selected 150 patients with residual insulin secretion.
Scientists have proved that in some cases the introduction of BCG with an interval of 4 weeks reduces the number of immune cells that damage the cells that produce insulin. This substance is essential for human body to process carbohydrates. With a lack of insulin, diabetes develops.
Not so long ago, scientists from Italy have opened another useful feature of a TB vaccine. The infusion, it turned out, reduces the activity of developing multiple sclerosis, an incurable disease that causes paralysis of the entire body.